Nxtcure Labs (YC F26) — Engineering the future of cancer drug discovery
Before you sell to, join or invest in Nxtcure Labs
MentionFox check on Nxtcure Labs: only 1 source on file so far (checked 7 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/yc-nxtcure-labs
Reinventing medicine from lab to drug discovery. NxtCure CRO- an AI-native, full-stack CRO built to take therapeutics from discovery to market faster.
Nxtcure Labs is a Y Combinator company in the Fall 2026 batch. Its directory entry describes it as: Engineering the future of Cancer Drug Discovery. The founders listed are Alessandro Hammond (Founder/CEO), Keanu Clark (Founder/CTO) (Y Combinator directory entry, September 17, 2026).
Get an email when Nxtcure Labs changes status, grows its team or files a funding notice. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
Reinventing medicine from lab to drug discovery.
NxtCure CRO- an AI-native, full-stack CRO built to take therapeutics from discovery to market faster.
NxtCure Cancer- the all-in-one mobile platform guiding patients through the cancer journey.
We’re building the operating system for the future of medicine.
Checked away from the directory entry. What is below does not come from the company's Y Combinator page.
Nxtcure Labs · The world’s most comprehensive cancer AI agent
Nxtcure Labs is the world’s most comprehensive cancer AI agent. Luna reads the full clinical picture, builds each patient a complete AI treatment plan, and carries them through to their first appointment.
The title and description the site itself served, answering 200. Not a cached copy and not the company's directory entry — what was live when we asked.
Alessandro Hammond
Founder/CEO
CEO @ NxtCure
Harvard ‘25, Phi Beta Kappa. Schwarzman Scholar (Tsinghua). MD/PhD at Yale
Founders, titles and bios as the company published them. Photographs are our own copies of the ones on that record, so they do not break when the original link expires.
One of 65 companies held here in Healthcare › Therapeutics.
No investor is drawn from a Form D — the form states how many invested and never who. The one investor on this graph is named because a batch has exactly one.
Want the whole picture on Nxtcure Labs?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Nxtcure Labs: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Nxtcure Labs covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
6 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
You get an alert in MentionFox the next time this company shows up.
Is this you?
If you're behind Nxtcure Labs: acceptance into a YC batch is one of the few weeks a young company gets looked up by people who matter — investors, other founders, press. FoxPlug turns the commits, deploys, and releases you're already making into that story automatically, so anyone who looks finds something current. GetFoxChat puts a guide on your own site so the people YC's own page just sent you don't read one line and leave.
